Identification of biomarkers and potential drug targets for esophageal cancer: a Mendelian randomization study

Identification of biomarkers and potential drug targets for esophageal cancer: a Mendelian randomization study

Abstract Esophageal cancer (EC) is a common and deadly malignancy of the digestive system. Currently, effective treatments for EC are limited and patient prognosis remains poor. In this study, we utilized Mendelian Randomization (MR) to identify potential drug targets for EC by analyzing proteins li...

Full description

Saved in:
Bibliographic Details
Main Authors: Chengjun Li, Xiaomeng Cui, Mudan Ren, Yan Yin, Shuixiang He
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
Esophageal cancer
Plasma protein
Druggable gene
Mendelian randomization
Drug target
Causality
Online Access:https://doi.org/10.1038/s41598-025-93068-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-93068-4

Similar Items